ADS Biotec strengthens its Scientific Advisory Board with appointments of new board members.
Appointment of two new Scientific Advisory Board members will help to guide the company’s ambitious growth plans.
March 2, 2023 – Omaha, USA: ADS Biotec, a global leader in development of automated instruments and bio-consumables including buffers for mRNA purification, is pleased to announce that it has added two new members to its Scientific Advisory Board to help guide the company’s ambitious growth plans. Following are joining the Advisory Board:
- Flavio Rizzolio is a molecular biologist at the Ca’Foscari University of Venice (Italy) in the Department of Molecular Sciences and Nanosystems. He has a PhD in Genetics, Oncology and Clinical Medicine and a specialty degree in Applied Genetics. He has led different national and international research programs in the field of cancer biology and nano medicine, publishing more than 100 peer reviewed scientific articles. Prof. Rizzolio is the founder and CEO of Biofuture Medicine, a biotech company with a focus on cancer
- Ninette Cohen is the Senior Director for the Division of Cytogenetics and Molecular Pathology in the Department of Pathology at Northwell Labs (Northwell Health, USA). Dr. Cohen has been a part of Northwell Labs leadership team since 2017, overseeing the clinical and academic activities of the genetic labs at North Shore University Hospital and Long Island Jewish Medical Center. Dr. Cohen is dual board certified in Clinical Cytogenetics and Clinical Molecular Genetics by the American Board of Medical Genetics and Genomics, is a Fellow of the American College of Medical Genetics and Genomics. Dr. Cohen’s area of interest include introducing innovative technology in the labs, medical education, quality improvement, lab communication and client relations.
” We are honored to have such highly distinguished and qualified members join our Scientific Advisory Board”, said Vijay Dube, CEO of ADS Biotec. “The new additions to our Advisory Board will add knowledge and valued experience to our company as we chart our growth plans for the future”.
” ADS Biotec is a leading player in lab automation and has ambitious growth plans in new biotech fields including cancer research”, said Prof. Flavio Rizzolio. “I am honored to be invited to join the company’s Advisory Board and look forward to contributing to the company’s new technology and product directions”.
” ADS Biotec is a well-respected and highly trusted supplier of Cytogenetic automation instruments and consumables”, said Dr. Ninette Cohen. “I am excited to join the company’s Advisory Board and look forward to supporting ADS Biotec as they further expand their offerings in the field of Cytogenetics and beyond”.
About ADS Biotec
ADS Biotec, along with its parent company ADSTEC, is a global leader in the development, manufacture and sale of automated instruments and bio-consumables for use in cytogenetic, pathology, molecular biology and research laboratories. Our flagship HANABI Metaphase Chromosome Harvesters and Spreaders designed for use by cytogenetic laboratories provide increased productivity and automated throughput with reliable and consistent quality. Our high-quality mRNA buffers and columns are used by leading Pharmaceutical and Biotech companies. ADS Biotec has a global presence with development, sales, and support operations on three continents, and supports system users in over 30 Countries. We are recognized by our customers for our advanced instrumentation, superior customer service, scientific application support, and its very knowledgeable sales force.
For More Information:
ADS Biotec Inc.
Stavros Papadimitriou – Vice President of Marketing